These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 29476414)
1. Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes. Berard L; Antonishyn N; Arcudi K; Blunden S; Cheng A; Goldenberg R; Harris S; Jones S; Mehan U; Morrell J; Roscoe R; Siemens R; Vallis M; Yale JF Diabetes Ther; 2018 Apr; 9(2):501-519. PubMed ID: 29476414 [TBL] [Abstract][Full Text] [Related]
2. Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method. Jain SM; Seshadri K; Unnikrishnan AG; Chawla M; Kalra P; Vipin VP; Ravishankar E; Chordia J; Das S; Wasir J; Bandookwala SM; Deka N; Agarwal G; Vijaykumar G; Erande S Diabetes Ther; 2020 Mar; 11(3):621-632. PubMed ID: 32009224 [TBL] [Abstract][Full Text] [Related]
3. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes. Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841 [TBL] [Abstract][Full Text] [Related]
4. Practical Guidance for Healthcare Providers on Collaborating with People with Type 2 Diabetes: Advancing Treatment and Initiating Injectable Therapy. Boeder S; Matamoros D; Mansy C Diabetes Ther; 2023 Feb; 14(2):425-446. PubMed ID: 36520406 [TBL] [Abstract][Full Text] [Related]
5. Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes. Wu T; Betty B; Downie M; Khanolkar M; Kilov G; Orr-Walker B; Senator G; Fulcher G Diabetes Ther; 2015 Sep; 6(3):273-87. PubMed ID: 26104878 [TBL] [Abstract][Full Text] [Related]
6. Behavioural interventions for type 2 diabetes: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526 [TBL] [Abstract][Full Text] [Related]
7. Practical Guidance on Basal Insulin Initiation and Titration in Asia: A Delphi-Based Consensus. Chan SP; Aamir AH; Bee YM; Deerochanawong C; Paz-Pacheco E; Tiu F; Foo SH; Tan KEK; Le TQ; Saraswati MR; Bunnag P; Panusunan Sibarani R; Raza SA; Tran NQ Diabetes Ther; 2022 Aug; 13(8):1511-1529. PubMed ID: 35767186 [TBL] [Abstract][Full Text] [Related]
8. Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes. Ross SA; Tildesley HD; Ashkenas J Curr Med Res Opin; 2011 Nov; 27 Suppl 3():13-20. PubMed ID: 21942467 [TBL] [Abstract][Full Text] [Related]
9. Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert OpinionĀ from an Indian Panel. Chawla M; Jain SM; Kesavadev J; Makkar BM; Viswanathan V; Tiwaskar M; Sosale AR; Negalur V; Modi KD; Gupta M; Kumar S; Ramakrishnan S; Deka N; Roy N Diabetes Ther; 2021 Jan; 12(1):133-142. PubMed ID: 33314000 [TBL] [Abstract][Full Text] [Related]
10. Community-based care for the management of type 2 diabetes: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(23):1-40. PubMed ID: 23074528 [TBL] [Abstract][Full Text] [Related]
11. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D). Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review. Matsuda E; Brennan P JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140 [TBL] [Abstract][Full Text] [Related]
13. Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns. Demir T; Turan S; Unluhizarci K; Topaloglu O; Tukek T; Gogas Yavuz D Front Endocrinol (Lausanne); 2021; 12():616514. PubMed ID: 33776914 [TBL] [Abstract][Full Text] [Related]
15. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Vinik A Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925 [TBL] [Abstract][Full Text] [Related]
16. Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?". Ghosal S; Sinha B; Majumder A; Das AK; Singh AK; Ghoshdastidar B; Maji D; Goyal G; Mukherjee JJ; Gangopadhyay KK; John M; Chatterjee S; Jaggi S; Ray S; Majumdar S; Sharma SK J Assoc Physicians India; 2017 Jul; 65(7):51-62. PubMed ID: 28792170 [TBL] [Abstract][Full Text] [Related]
17. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Vinik A Clin Ther; 2007 Jun; 29(6 Pt 1):1236-53. PubMed ID: 18036387 [TBL] [Abstract][Full Text] [Related]
18. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393 [TBL] [Abstract][Full Text] [Related]
19. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus. Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296 [TBL] [Abstract][Full Text] [Related]